Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MDLZ vs GSK✓SelectedUSD · GSKMDLZ vs GSK performance historyLatest closeAs of0.00%11/16
Stock and ETF performance explorer

MDLZ vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+23.8%
GSK return
+46.9%
Excess return
-23.1%
Maximum drawdown
-29.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D0.0%-0.1%+0.1%0.0%
7D+1.7%-1.3%+3.0%+1.9%
30D+5.7%+2.7%+2.9%+5.1%
3M+7.1%+2.7%+4.4%+6.4%
6M+13.7%+3.3%+10.4%+12.8%
YTD+28.7%+6.5%+22.3%+26.3%
1Y+23.0%+10.7%+12.3%+19.7%
3Y+4.6%+64.4%-59.8%-8.2%
5Y+23.8%+46.7%-22.9%+9.0%
All+23.8%+46.9%-23.1%+9.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling